Boardroom Alpha
Boardroom Alpha
LULU · Current Report (Form 8-K) · Filed June 26, 2026

Lululemon Athletica Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 26, 2026
Period
Jun 24, 2026
Ticker
LULU
Accession
0001397187-26-000088
Boardroom Alpha · Filing insights

lululemon expands board to 11 by appointing Gentile and Maurer as independent directors after the 2026 annual meeting.

About Lululemon Athletica Inc
Market cap
$12.5B
1Y TSR
−39.0%
3Y TSR
−31.6%
Board grade
C
Sector
Consumer Cyclical
CEO
Heidi O'Neill
Last annual meeting: Jun 11, 2025 · View full Lululemon Athletica Inc profile →
lulu-20260624

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
June 24, 2026
Date of Report (Date of earliest event reported)
lululemon_Yogo_Black.jpg
lululemon athletica inc.
(Exact name of registrant as specified in its charter)
 
Delaware001-3360820-3842867
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
1818 Cornwall Avenue
Vancouver, British Columbia
Canada, V6J 1C7
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (604) 732-6124
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, par value $0.005 per shareLULUNasdaq Global Select Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On June 24, 2026, the board of directors (the “Board”) of lululemon athletica inc. (the “Company”) appointed Laura Gentile and Marc Maurer as members of the Board, effective immediately following the conclusion of the 2026 annual meeting of stockholders held on June 25, 2026 (the “Annual Meeting”), and increased the size of the Board from 9 to 11 members in connection with such appointments. Such appointments were made pursuant to the previously disclosed Cooperation Agreement by and between the Company and Dennis J. “Chip” Wilson, Anamered Investments Inc., LIPO Investments (USA), Inc., Wilson 5 Foundation, Wilson 5 Foundation Management Ltd., Five Boys Investments ULC, Shannon Wilson, Low Tide Properties Ltd. and House of Wilson Ltd, dated May 26, 2026.

Ms. Gentile has been appointed to serve as a Class I director and Mr. Maurer has been appointed to serve as a Class III director. Ms. Gentile and Mr. Maurer have been appointed to serve on the Audit Committee and Corporate Responsibility, Sustainability and Governance Committee. The Board has determined that Ms. Gentile and Mr. Maurer each qualifies as an “independent” director under Nasdaq listing standards.

Other than as described in this Item 5.02, there are no arrangements or understandings between Ms. Gentile or Mr. Maurer and any other person pursuant to which either was selected as a director. There are no transactions in which Ms. Gentile or Mr. Maurer has a direct or indirect material interest requiring disclosure under Item 404(a) of Regulation S-K. Ms. Gentile and Mr. Maurer will each receive standard compensation for their service as a director consistent with that of the Company’s other non-employee directors. The Company expects Ms. Gentile and Mr. Maurer to enter into its standard form indemnification agreement for non-employee directors.

Item 5.07.Submission of Matters to a Vote of Security Holders
At the Annual Meeting, the matters on which the stockholders voted, in person or by proxy, which are described in more detail in the Company’s proxy materials for the Annual Meeting, were:

1.to elect three Class I directors to hold a three-year term and until each director's respective successors are elected and qualified;
2.to ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027;
3.to approve, on an advisory basis, the compensation of our named executive officers;
4.to approve an amendment to the 2023 Equity Incentive Plan to increase the share reserve; and
5.to vote on a stockholder proposal regarding the declassification of the Board.
The results of the voting were as follows:
Election of Directors:
Class I DirectorVotes ForVotes WithheldBroker Non-Votes
Charles (Chip) Bergh71,627,2951,959,2761,354,452
Esi Eggleston Bracey72,103,3301,483,2411,354,452
Teri List67,396,2456,190,3261,354,452
Each of the foregoing nominees was elected to serve until the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified.
Ratification of Selection of Independent Registered Public Accounting Firm:
Votes ForVotes AgainstVotes Abstained
PricewaterhouseCoopers LLP71,434,1763,419,87186,976
The foregoing proposal was approved.



Approval, on an Advisory Basis, of Executive Compensation:
Votes ForVotes AgainstVotes AbstainedBroker Non-Votes
Executive Compensation46,416,59327,018,492151,4861,354,452
The foregoing proposal was approved.
Approval of Amendment to 2023 Equity Incentive Plan:
Votes ForVotes AgainstVotes AbstainedBroker Non-Votes
Share Reserve Increase70,484,5642,994,359107,6481,354,452
The foregoing proposal was approved.
Stockholder Proposal Regarding the Declassification of the Board:
Votes ForVotes AgainstVotes AbstainedBroker Non-Votes
Declassification of the Board of Directors73,105,842320,258160,4711,354,452
The foregoing proposal was approved.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
lululemon athletica inc.
Dated: June 25, 2026/s/ MEGHAN FRANK
Meghan Frank
Interim Co-Chief Executive Officer and Chief Financial Officer


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Lululemon Athletica Inc (LULU)

Reference

Frequently asked questions

When did Lululemon Athletica Inc file this 8-K?
Lululemon Athletica Inc (LULU) filed this Current Report (Form 8-K) with the SEC on June 26, 2026. The accession number assigned by EDGAR is 0001397187-26-000088.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
lululemon expands board to 11 by appointing Gentile and Maurer as independent directors after the 2026 annual meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Lululemon Athletica Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Lululemon Athletica Inc has filed under CIK 1397187, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer